Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
CELLJUVANT CELL-BASED ADJUVANT
TECHNOLOGY
Registered
on 16 Feb 2022
Last Applicant/ Owned by
Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina, 27540
Serial Number
UK00003755649 filed on 16th Feb 2022
Registration Number
UK00003755649 registered on
13th May 2022
Correspondent Address
280 Bishopsgate
London,
EC2M 4AG
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY
vaccines; vaccines for human use; flu vaccines.
conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccin Read More
Classification Information
Class [5]
Pharmaceutical Products
Vaccines; vaccines for human use; flu vaccines.
Class [42]
Computer & Software Services & Scientific Services
Conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccines; providing information about the results of clinical trials for flu vaccines; providing medical and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development.
Class [44]
Medical, Beauty & Agricultural Services
Pharmaceutical and medical information.
Mark Details
Serial Number
UK00003755649
Mark Type
Word
Kind of mark
Individual